Please login to the form below

Not currently logged in
Email:
Password:

selonsertib

This page shows the latest selonsertib news and features for those working in and with pharma, biotech and healthcare.

Gilead strikes $5.1bn deal to bolster ties with Galapagos

Gilead strikes $5.1bn deal to bolster ties with Galapagos

Meanwhile, Gilead has had a couple of failed trials with its lead non-alcoholic steatohepatitis (NASH) therapy selonsertib.

Latest news

  • Boehringer bolsters NASH pipeline with $870m Yuhan deal Boehringer bolsters NASH pipeline with $870m Yuhan deal

    Among the big players is Gilead, which recently reported two failed phase 3 trials for ASK1 inhibitor selonsertib and has previously had to abandon two other candidates (simtuzumab and Px-102). ... It’s now hoping for better results from a combination

  • Genfit presses the gas on NASH with combo trials Genfit presses the gas on NASH with combo trials

    moment. It’s notable that Gilead now has a two disappointing late-stage trial readouts for its ASK1 inhibitor selonsertib in NASH, while front-runner Intercept is pitching its candidate Ocaliva

  • Gilead's NASH drug fails again Gilead's NASH drug fails again

    Drug failed to match results from placebo group. Gilead's chances of winning the first-to-market nonalcoholic steatohepatitis (NASH) race has dwindled after one of its key candidates selonsertib failed ... Gilead was hit with very similar news two months

  • Gilead drives NASH development with insitro collaboration Gilead drives NASH development with insitro collaboration

    The move comes not long after the drugmaker released some disappointing late-stage results for its NASH candidate selonsertib, which failed to meet its main goal of improving fibrosis without worsening

  • Novo Nordisk and Gilead join forces in NASH Novo Nordisk and Gilead join forces in NASH

    Gilead has a number of NASH drugs in its pipeline, including a three drug regimen with selonsertib at the core.

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics